IPO

Valiant Laboratories Limited IPO

Mainboard

Commodity Chemicals

Listed On: Oct 6, 2023 at ₹ 162.15(NSE)

₹ 14700 /105 Shares

Check Allotment

27 Sep, 2023

Open Date

03 Oct, 2023

Close Date

04 Oct, 2023

Allotment Date

06 Oct, 2023

Listing Date
Price Summary

Last Closing

67.93 (-51.48%)

52 Week High

120.85

52 Week Low

63.86

Last Update

19-Dec-2025 3:30 PM
Valiant Laboratories Limited IPO Issue Details
  • Issue Price ₹133-140 per equity share
  • Face Value ₹10 Per Equity Share
  • Issue Price 11,556,000 shares (aggregating up to ₹152 Cr)
    #Fresh Issue: 11,556,000 shares (aggregating up to ₹152 Cr)
  • Listing at BSE, NSE
  • List Price 162.15(NSE)
  • Listing Date 2023-10-06
  • Lead Manager Unistone Capital Private Limited
  • Registrar Link Intime India Private Ltd
Valiant Laboratories Limited IPO Details
  • Retail Portion 35% (Number of Retail Applications: 36,300 Approx),
    (Number of S-HNI Applications : 370 Approx),
    (Number of B-HNI Applications : 741 Approx)
Valiant Laboratories Limited IPO Documents
DRHP
RHP
ANCHOR
Valiant Laboratories Limited IPO Details


The IPO of Valiant Laboratories Limited is priced at ₹133-140 per equity share, which has a face value of ₹10 Per Equity Share each, IPO bidding starts from Sep 27, 2023 and ends on Oct 3, 2023. The allotment for Valiant Laboratories Limited IPO will be finalized on Oct 4, 2023. Valiant Laboratories Limited IPO will be listed on BSE, NSE, with a tentative listing date fixed as Oct 6, 2023. The company shall list its equity shares on the BSE, NSE. Link Intime India Private Ltd is the registrar of the issue.

The book-running lead manager for the IPO is/are Unistone Capital Private Limited.


The Valiant Laboratories Limited IPO sets its price band at 133-140 for each share. A single application for Valiant Laboratories Limited IPO must contain at least 105 shares.

Read More
Valiant Laboratories Limited IPO Subscription Analysis And Details
Retail
16.05x
QIB
20.83x
NII
73.63x
bNII
78.64x
sNII
63.62x
Total
29.75x
As on QIB NII
bNII   sNII 		Retail Total
Shares Offered / Reserved 2,178,030 1,633,500
1,088,999    544,501 		3,811,500 7,623,030
Day 1 27-09-23 05:00 PM
0.00 x 0.10
0.xx x   0.xx x 		0.62 x 0.33 x
Day 2 28-09-23 05:00 PM
0.05 x 0.29
0.xx x   0.xx x 		1.29 x 0.72 x
Day 3 29-09-23 05:00 PM
1.04 x 1.52
6.09 x   3.35 x 		3.14 x 2.19 x
Day 4 03-10-23 05:00 PM
20.83 x 73.63
78.64 x   63.62 x 		16.05 x 29.75 x
Total No of Applications
675,925
Valiant Laboratories Limited Valuations
Earnings Per Share (EPS) ₹8.91/-
P/E Ratio 15.71
RoNW 28.86%
Net Asset Value (NAV) - As on 31.03.22 ₹N/A
Valiant Laboratories Limited Company Financials
In Crs.
In Cr.
31-Mar-23 31-Mar-22 31-Mar-21
Assets 212.76 181.81 106.31
Revenue 338.77 293.47 183.78
Profit After Tax 29.00 27.50 30.59
About Valiant Laboratories Limited Company

Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing company in India having focuses on manufacturing Paracetamol.

The company's manufacturing unit is located in Palghar, Maharashtra, spread across 2,000 sq. mts. of land with an aggregate annual total installed capacity of 9,000 MT per annum. Valiant Laboratories also has an R&D Facility, equipped with an analytical laboratory and infrastructure for developmental activities in existing products.

For the Fiscal 2023, Fiscal 2022 and Fiscal 2021, Valiant Laboratories revenue from operations was Rs. 3,339.10 million, Rs. 2,915.23 million and Rs. 1,823.69 million, respectively.

Valiant Laboratories Limited imports Para Amino Phenol, being the raw material for the manufacture of Paracetamol from China and Cambodia.

As of April 30, 2023, Valiant Laboratories has 86 employees.

Read More
Valiant Laboratories Limited - Promoter(s)

Shantilal Shivji Vora

Dhanvallabh Ventures LLP (DVL)

Pre Issue Share Holding : 100%

Post Issue Share Holding : 74.94%

Valiant Laboratories Limited IPO - Issue Objectives
1

Investment in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).

2

Investment in VASPL for funding its working capital requirements.

3

General corporate purposes.

Valiant Laboratories Limited IPO - Anchor Investors

Valiant Laboratories raises Rs 45.74 crore via anchor book ahead of IPO.

Leading Light Fund VCC - The Triumph Fund is the largest investor among four anchor investors, buying 14.81 lakh shares worth Rs 20.73 crore.

Saint Capital Fund and Astorne Captal VCC - Arven together invested Rs 20 crore for 7.14 lakh shares each, while Negen Undiscovered Value Fund is the fourth participant, buying 3.57 lakh shares worth Rs 5 crore.